HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease.

ABSTRACT: Physicians use portal pressure measurements in clinical practice and research but the methods are invasive, can cause complications, and are resource intensive.^1-3 Herein we describe preliminary findings of the minimally invasive HepQuant-SHUNT test in the diagnosis of portal hypertension in precirrhotic and compensated cirrhotic patients.

SUBMITTER: Wieland A 

PROVIDER: S-EPMC8531144 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature